Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
Quarterly results
Credit agrmnt [a]
Appointed director
Director departure
THERAGENICS CORP (TGX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/13/2014 SC 13G/A RENAISSANCE TECHNOLOGIES LLC reports a 0% stake in THERAGENICS CORPORATION
02/10/2014 SC 13G/A DIMENSIONAL FUND ADVISORS LP reports a 0% stake in THERAGENICS CORP
11/12/2013 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
11/06/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/06/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/06/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/06/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/06/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/06/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/06/2013 EFFECT Form EFFECT - Notice of Effectiveness
11/06/2013 EFFECT Form EFFECT - Notice of Effectiveness
11/04/2013 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp...
Docs: "Amended and Restated Certificate of Incorporation of Theragenics Corporation as of October 29, 2013",
"Amended and Restated Bylaws of Theragenics Corporation as of October 29, 2013"
10/31/2013 4 Small C. Russell (VP, NeedleTech Products) has filed a Form 4 on THERAGENICS CORP
Txns: Disposed/sold 68,162 shares @ $2.2, valued at $150k
Disposed/sold 230,250 shares @ $2.2, valued at $506.6k
Disposed/sold 34,000 options to buy @ $0.93, valued at $31.6k
Disposed/sold 47,000 options to buy @ $1.44, valued at $67.7k
Disposed/sold 58,200 options to buy @ $1.71, valued at $99.5k
10/31/2013 4 Plante Joseph (President, NeedleTech Products) has filed a Form 4 on THERAGENICS CORP
Txns: Disposed/sold 54,308 shares @ $2.2, valued at $119.5k
Disposed/sold 219,175 shares @ $2.2, valued at $482.2k
Disposed/sold 47,000 options to buy @ $1.44, valued at $67.7k
Disposed/sold 58,200 options to buy @ $1.71, valued at $99.5k
10/31/2013 4 Zeman Janet (President, CP Medical) has filed a Form 4 on THERAGENICS CORP
Txns: Disposed/sold 68,182 shares @ $2.2, valued at $150k
Disposed/sold 235,962 shares @ $2.2, valued at $519.1k
Disposed/sold 34,000 options to buy @ $0.93, valued at $31.6k
Disposed/sold 47,000 options to buy @ $1.44, valued at $67.7k
Disposed/sold 58,200 options to buy @ $1.71, valued at $99.5k
10/31/2013 4 Tarallo Francis J (CFO) has filed a Form 4 on THERAGENICS CORP
Txns: Disposed/sold 136,364 shares @ $2.2, valued at $300k
Disposed/sold 301,308 shares @ $2.2, valued at $662.9k
Disposed/sold 40,000 options to buy @ $0.93, valued at $37.2k
Disposed/sold 57,000 options to buy @ $1.44, valued at $82.1k
Disposed/sold 71,100 options to buy @ $1.71, valued at $121.6k
10/31/2013 4 SMITH BRUCE W (Exec. VP) has filed a Form 4 on THERAGENICS CORP
Txns: Disposed/sold 532,798 shares @ $2.2, valued at $1.2M
Disposed/sold 34,000 options to buy @ $0.93, valued at $31.6k
Disposed/sold 52,000 options to buy @ $1.44, valued at $74.9k
Disposed/sold 67,900 options to buy @ $1.71, valued at $116.1k
10/31/2013 4 JACOBS M CHRISTINE (CEO) has filed a Form 4 on THERAGENICS CORP
Txns: Disposed/sold 946,523 shares @ $2.2, valued at $2.1M
Disposed/sold 80,000 options to buy @ $0.93, valued at $74.4k
Disposed/sold 70,400 options to buy @ $1.44, valued at $101.4k
Disposed/sold 109,900 options to buy @ $1.71, valued at $187.9k
10/31/2013 4 SAUNDERS PETER A A (Director) has filed a Form 4 on THERAGENICS CORP
Txns: Disposed/sold 139,000 shares @ $2.2, valued at $305.8k
Disposed/sold 5,000 options to buy @ $1.02, valued at $5.1k
Disposed/sold 5,000 options to buy @ $1.33, valued at $6.7k
10/31/2013 4 MOODY CHARLES D JR (Director) has filed a Form 4 on THERAGENICS CORP
Txns: Disposed/sold 117,318 shares @ $2.2, valued at $258.1k
Disposed/sold 5,000 options to buy @ $1.02, valued at $5.1k
Disposed/sold 5,000 options to buy @ $1.33, valued at $6.7k
10/31/2013 4 Engwall K Wyatt (Director) has filed a Form 4 on THERAGENICS CORP
Txns: Disposed/sold 209,550 shares @ $2.2, valued at $461k
Disposed/sold 5,000 options to buy @ $1.02, valued at $5.1k
Disposed/sold 5,000 options to buy @ $1.33, valued at $6.7k
10/31/2013 4 DAHLBERG KATHLEEN (Director) has filed a Form 4 on THERAGENICS CORP
Txns: Disposed/sold 90,000 shares @ $2.2, valued at $198k
Disposed/sold 5,000 options to buy @ $1.02, valued at $5.1k
Disposed/sold 5,000 options to buy @ $1.33, valued at $6.7k
10/31/2013 4 HERNDON JOHN V (Director) has filed a Form 4 on THERAGENICS CORP
Txns: Disposed/sold 128,424 shares @ $2.2, valued at $282.5k
Disposed/sold 5,000 options to buy @ $1.02, valued at $5.1k
Disposed/sold 5,000 options to buy @ $1.33, valued at $6.7k
10/31/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
10/31/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
10/30/2013 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
10/22/2013 8-K Quarterly results
10/07/2013 8-K Other Events
10/07/2013 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
09/16/2013 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
09/09/2013 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
08/13/2013 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
08/13/2013 10-Q Quarterly Report for the period ended June 30, 2013
08/12/2013 SC 13D GMMF Equity Holdings LLC reports a 0% stake in Theragenics Corporation
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy